Wegovy 1.7 MG/0.75 ML pen 0.75ML
Ended Awarded
- Contract number
- SPE2DB25FJM31
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,705
Award facts
- Contract value 100% obligated
- $10,705.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,705.08 to AmerisourceBergen Drug Corp for the supply of Wegovy 1.7 mg/0.75 mL pen injectors on August 18, 2025, with an ultimate completion date of August 19, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of pharmaceutical products and medical supplies across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard. The delivery order for Wegovy, a GLP-1 receptor agonist medication, exemplifies the company's role in providing specialized pharmaceutical products to support federal healthcare programs. This award reflects AmerisourceBergen's demonstrated capability to fulfill federal procurement requirements and its significance within the DLA's medical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DB25FJM31?
SPE2DB25FJM31 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 18, 2025.
How much is contract SPE2DB25FJM31 worth?
The government has obligated $10,705 on SPE2DB25FJM31.
Is contract SPE2DB25FJM31 an order under another contract?
Yes. SPE2DB25FJM31 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJM31 competed?
The extent of competition for SPE2DB25FJM31 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award